Primary progression during frontline CIT associates with decreased efficacy of subsequent CD19 CAR T-cell therapy in LBCL
- Resource Type
- Source
- Blood Advances. 6:3970-3973
- Subject
T-Lymphocytes Antigens, CD19 Blood Proteins Hematology Immunotherapy, Adoptive - Language
- ISSN
- 2473-9537
2473-9529